Nektar Therapeutics (NKTR) EPS (Weighted Average and Diluted): 2013-2025
Historic EPS (Weighted Average and Diluted) for Nektar Therapeutics (NKTR) over the last 10 years, with Sep 2025 value amounting to -$1.87.
- Nektar Therapeutics' EPS (Weighted Average and Diluted) rose 29.70% to -$1.87 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.63, marking a year-over-year increase of 153.15%. This contributed to the annual value of -$0.58 for FY2024, which is 60.00% up from last year.
- Per Nektar Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$1.87 for Q3 2025, which was up 36.61% from -$2.95 recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' EPS (Weighted Average and Diluted) registered a high of $8.69 during Q4 2024, and its lowest value of -$790 during Q4 2021.
- Over the past 3 years, Nektar Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.27 (recorded in 2023), while the average stood at -$0.40.
- In the last 5 years, Nektar Therapeutics' EPS (Weighted Average and Diluted) tumbled by 121,438.46% in 2021 and then skyrocketed by 4,050.00% in 2024.
- Quarterly analysis of 5 years shows Nektar Therapeutics' EPS (Weighted Average and Diluted) stood at -$790 in 2021, then skyrocketed by 99.96% to -$0.32 in 2022, then soared by 31.25% to -$0.22 in 2023, then soared by 4,050.00% to $8.69 in 2024, then increased by 29.70% to -$1.87 in 2025.
- Its last three reported values are -$1.87 in Q3 2025, -$2.95 for Q2 2025, and -$0.24 during Q1 2025.